Enzalutamide – March 2026

Capsule 40 mg

  • Brand names:
    • Xtandi®
  • Pharmaceutical Company:
    • ASTELLAS PHARMA AUSTRALIA PTY LTD
  • Condition/Indication: Non-metastatic hormone sensitive prostate cancer (nmHSPC)
  • Meeting Date: March 2026
Public Summary Documents
Last updated
11 March 2026